MedTrace Logo

Investigation of Desmoplastic Squamous Cell Carcinoma

NCT02717936 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2016-03-25

No results posted yet for this study

Summary

Aim of the study is to verify wether it is possible to have a more sensitive diagnostic tool using pancytokeratin immunohistochemistry for desmoplastic squamous cell carcinoma compared to regular H\&E staining. The investigators therefore plan to include 73 participants with a confirmed diagnosis of desmoplastic squamous cell carcinoma and do regular follow up.

Conditions

  • Squamous Cell Carcinoma of the Skin

Interventions

PROCEDURE

Immunohistochemistry using Pancytokeratin Staining

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-01-31
Completion
2020-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02717936 on ClinicalTrials.gov